g interventional procedures. ... Adding the pre-loaded system to our product offerings demonstrates Bo... About Uterine FibroidsUterine fibroids are non-cancerous growths th... About Liver CancerLiver cancer is one of the most commonly diagnose...

"Adding the pre-loaded system to our product offerings demonstrates Boston Scientific's commitment to providing a comprehensive suite of less-invasive solutions for interventional radiologists and their patients," said Joe Fitzgerald, Senior Vice President and President of Boston Scientific's Endovascular Unit. "We will continue to bring additional technologies to market that advance the various therapies performed by specialists in vascular and interventional radiology."

About Uterine FibroidsUterine fibroids are non-cancerous growths that develop in the muscular wall of the uterus or cervix, and are estimated to occur in up to 40 percent of women of child-bearing age. Although most uterine fibroids are asymptomatic, some can cause heavy and painful menstrual bleeding, pelvic pressure and frequent urination. Treatment options include medication, hysterectomy, myomectomy (surgical removal of fibroids from the uterus) and uterine artery embolization (UAE). In UAE, a physician uses minimally invasive techniques under local anesthesia to access and occlude both uterine arteries, reducing or eliminating blood flow to the fibroid. Uterine fibroids are the most common benign tumors in women and are the most frequent indication for hysterectomy among pre-menopausal women.

About Liver CancerLiver cancer is one of the most commonly diagnosed forms of cancer worldwide, with more than 800,000 patients diagnosed annually. The average life expectancy of many patients with liver cancer is less than one year. Treatment options include surgical resection, chemotherapy, radiation, tumor ablation, and several minimally invasive options, including transarterial chemoembolization (TACE) and radioembolization. In the minimally invasive options, a physician will establish endovascular access to the hepatic artery under local anesthesia to deliver one of several acute therapies.'/>"/>

(Date:3/3/2015)... 3, 2015 Based on its recent ... & Sullivan recognizes Neopeutics, Inc. with the 2015 ... Leadership. Neopeutics has demonstrated a remarkable ability to ... easily adaptable set of drug discovery instruments. It ... failing compounds in the early stages of the ...

... GlaxoSmithKline (NYSE:,GSK), one of the world,s largest ... order to purchase bulk H5N1 antigen for the ... announced the,start of the first North American pre-pandemic ... HHS Order The company has received ...

... N.J., Aug. 6 MicroDose Technologies,Inc., a ... company,today announces top line results from a ... product. MicroDose, through its joint venture with ... highly efficient, rapid acting,insulin inhaler, based upon ...

(Date:3/3/2015)... (PRWEB) March 04, 2015 The report ... on the therapeutic development for Alopecia. Alopecia is the ... the two main types of alopecia. Causes for alopecia ... Symptoms of alopecia may include male pattern hair loss, ... hair. Alopecia can be classified as focal or diffuse ...

(Date:3/3/2015)... (PRWEB) March 03, 2015 The first ... the National Sleep Foundation. The event brings recognition to ... over. , According to the Centers for ... problems of one form or another. Too little or ... risk of physical illness and depression, and even a ...

(Date:3/3/2015)... 2015 The combinatorial, multi-gene GeneSight ... treatment outcomes for patients with depression, and their ... the individual genes that comprise the test, according ... Mayo Clinic and Assurex Health, and published online ... proprietary technology of the GeneSight Psychotropic test is ...

(Date:3/3/2015)... 2015 The North America ... grow from $1,224.6 million to $1,694.6 million, ... and 2019. , Browse through the TOC ... for an analysis of industry trends and ... and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html , An ...

... Through a new advertising campaign being launched in Memphis today, ... and prevention. Cervical cancer is caused by high-risk types ... the only FDA-approved HPV test, has selected Memphis as a ... ad for the digene HPV Test on local ...

... Family, Encourage Charitable Giving , BOSTON, Feb. 9 ... today launched the ,Light a Candle, program -- offering consumers ... their loved ones. Visitors can now light candles or ... million current and historical obituaries available on the popular national ...

... Television Week for providing "vital information" to viewers, ... program that tells the compelling and inspirational stories of real ... Denver, CO; Albany, NY; Austin, TX; Salt Lake City, UT; ... the program now airs on nearly 260 television stations across ...

... MINNEAPOLIS, Feb. 9 ARKRAY USA, Inc., the 5th ... clearance from,the U.S. Food and Drug Administration for the ... This new system requires no coding, displays results ... size, and was developed to use the same,affordable test ...

... to learn about Heart Failure-how to prevent it and to ... Week February 8-14, 2009 Heart Failure Society of ... Available at www.abouthf.org NEW YORK, ... for February 8-14. This is a time for ...

The STALIF stand-alone anterior lumbar fusion cage is the latest product development from Surgicraft. STALIF is the natural evolution of the Hartshill Horseshoe, which has over 10 years clinical suc...

... Computerized Vision Tester offers the latest ... the many features of our complete ... delegating the refraction, electronic data collection, ... an incredible interest in this product! ...